Literature DB >> 18558863

The prion's elusive reason for being.

Adriano Aguzzi1, Frank Baumann, Juliane Bremer.   

Abstract

The protein-only hypothesis posits that the infectious agent causing transmissible spongiform encephalopathies consists of protein and lacks any informational nucleic acids. This agent, termed prion by Stanley Prusiner, is thought to consist partly of PrP(Sc), a conformational isoform of a normal cellular protein termed PrP(C). Scientists and lay persons have been fascinated by the prion concept, and it has been subjected to passionate critique and intense experimental scrutiny. As a result, PrP(C) and its isoforms rank among the most intensively studied proteins encoded by the mammalian genome. Despite all this research, both the physiological function of PrP(C) and the molecular pathways leading to neurodegeneration in prion disease remain unknown. Here we review the salient traits of those diseases ascribed to improper behavior of the prion protein and highlight how the physiological functions of PrP(C) may help explain the toxic phenotypes observed in prion disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18558863     DOI: 10.1146/annurev.neuro.31.060407.125620

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  193 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.

Authors:  Piero Parchi; Maura Cescatti; Silvio Notari; Walter J Schulz-Schaeffer; Sabina Capellari; Armin Giese; Wen-Quan Zou; Hans Kretzschmar; Bernardino Ghetti; Paul Brown
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

3.  Probing the conformation of a prion protein fibril with hydrogen exchange.

Authors:  Steven M Damo; Aaron H Phillips; Anisa L Young; Sheng Li; Virgil L Woods; David E Wemmer
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

4.  Cellular prion protein promotes regeneration of adult muscle tissue.

Authors:  Roberto Stella; Maria Lina Massimino; Marco Sandri; M Catia Sorgato; Alessandro Bertoli
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

5.  Discrimination between alternate membrane protein topologies in living cells using GFP/YFP tagging and pH exchange.

Authors:  Beatriz Domingo; María Gasset; Mario Durán-Prado; Justo P Castaño; Antonio Serrano; Thierry Fischer; Juan Llopis
Journal:  Cell Mol Life Sci       Date:  2010-05-08       Impact factor: 9.261

6.  The structural intolerance of the PrP alpha-fold for polar substitution of the helix-3 methionines.

Authors:  Silvia Lisa; Massimiliano Meli; Gema Cabello; Ruth Gabizon; Giorgio Colombo; María Gasset
Journal:  Cell Mol Life Sci       Date:  2010-05-09       Impact factor: 9.261

7.  Conversion of bacterially expressed recombinant prion protein.

Authors:  Fei Wang; Xinhe Wang; Jiyan Ma
Journal:  Methods       Date:  2010-12-19       Impact factor: 3.608

8.  Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors.

Authors:  Haitao You; Shigeki Tsutsui; Shahid Hameed; Thomas J Kannanayakal; Lina Chen; Peng Xia; Jordan D T Engbers; Stuart A Lipton; Peter K Stys; Gerald W Zamponi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

9.  A bacterial global regulator forms a prion.

Authors:  Andy H Yuan; Ann Hochschild
Journal:  Science       Date:  2017-01-13       Impact factor: 47.728

10.  Thy1 associates with the cation channel subunit HCN4 in adult rat retina.

Authors:  Gloria J Partida; Tyler W Stradleigh; Genki Ogata; Iv Godzdanker; Andrew T Ishida
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-26       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.